Laminitis and the equine metabolic syndrome

Veterinary Clinics of North America - Equine Practice

Volumn 26, Issue 2, 2010, Pages 239-255

  Johnson, Philip J ^a   Wiedmeyer, Charles E ^a   LaCarrubba, Alison ^a   Seshu Ganjam, V K ^a   Messer, Nat T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Endocrinopathic laminitis; Equine metabolic syndrome; Insulin resistance; Obesity

Indexed keywords

ANIMAL; ANIMAL DISEASE; FOOT DISEASE; GENETICS; HOOF AND CLAW; HORSE; HORSE DISEASE; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISORDER; PATHOLOGY; REVIEW;

ANIMALS; FOOT DISEASES; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISEASES;

EQUIDAE;

EID: 77955475523     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.04.004     Document Type: Review

References (82)

1. Belknap J.K., Moore J.N., Crouser E.C. Sepsis-From human organ failure to laminar failure. Vet Immunol Immunopathol 2009, 129(3-4):155-157.
2. Loftus J.P., Johnson P.J., Belknap J.K., et al. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol 2009, 129(3-4):221-230.
3. Moore J.N., Belknap J.K. You say lamellae, I say laminae. Let's call. An overview of the Havemeyer workshop on laminitis pathophysiology. Vet Immunol Immunopathol 2009, 129(3-4):149-150.
4. Bailey S.R., Adair H.S., Reinemeyer C.R., et al. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet Immunol Immunopathol 2009, 129(3-4):167-173.
5. Budak M.T., Orsini J.A., Pollitt C.C., et al. Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse. Vet Immunol Immunopathol 2009, 131(1-2):86-96.
6. Geor R., Frank N. Metabolic syndrome-From human organ disease to laminar failure in equids. Vet Immunol Immunopathol 2009, 129(3-4):151-154.
7. Pleasant R.S., Thatcher C. Prevention of pasture-associated laminitis. Current therapy in equine medicine 2009, 547-549. Saunders, Elsevier, St Louis (MO). 6th edition. N.E. Robinson, K.A. Sprayberry (Eds.).
8. Johnson P.J., Messer N.T., Ganjam V.K. Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine Vet J 2004, 36(3):194-198.
9. Johnson P.J., Messer N.T., Slight S.H., et al. Endocrinopathic laminitis in the horse. Clin Tech Equine Pract 2004, 3(1):45-56.
10. Haffner J.C., Eiler H., Hoffman R.M., et al. Effect of a single dose of dexamethasone on glucose homeostasis in healthy horses by using the combined intravenous glucose and insulin test. J Anim Sci 2009, 87(1):131-135.
11. Tiley H.A., Geor R.J., McCutcheon L.J. Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. Am J Vet Res 2007, 68(7):753-759.
12. Geor R.J. Pasture-associated laminitis. Vet Clin North Am Equine Pract 2009, 25(1):39-50.
13. Carter R.A., Treiber K.H., Geor R.J., et al. Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine Vet J 2009, 41(2):171-178.
14. Usda-Nahms. Lameness and laminitis in US horses (monograph). In: United States Department of Agriculture National Animal Health Monitoring System. April 2000. #N318.0400.
15. Hinckley K, Henderson I. The epidemiology of equine laminitis in the UK. Warwick (UK): 35th Congress of the British Equine Veterinary Association; 1996. p. 62.
16. Tóth F., Frank N., Elliott S.B., et al. Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses. Am J Vet Res 2008, 69(1):82-88.
17. Zhou M.S., Schulman I.H., Raij L. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens 2010, 28(3):527-535.
18. Kalck K.A., Frank N., Elliott S.B., et al. Effects of low-dose oligofructose treatment administered via nasogastric intubation on induction of laminitis and associated alterations in glucose and insulin dynamics in horses. Am J Vet Res 2009, 70(5):624-632.
19. Johnson P.J. Equine metabolic syndrome (" Peripheral Cushing's Syndrome" ). Vet Clin North Am Equine Pract 2002, 18:271-293.
20. Frank N., Geor RJ., Bailey SR., et al. Equine Metabolic Syndrome. J Vet Intern Med Apr 2 2010, [Epub ahead of print].
21. Robinson L.E., Graham T.E. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can J Appl Physiol 2004, 29(6):808-829.
22. Kronfeld D.S., Treiber K.H., Hess T.M., et al. Metabolic syndrome in healthy ponies facilitates nutritional countermeasures against pasture laminitis. J Nutr 2006, 136(Suppl 7). 2090S-3S.
23. Treiber K.H., Kronfeld D.S., Hess T.M., et al. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 2006, 228(10):1538-1545.
24. Longland A.C., Byrd B.M. Pasture nonstructural carbohydrates and equine laminitis. J Nutr 2006, 136. 2099S-102S.
25. Longland A.C. Starch, sugar and fructans: what are they and how important are they in diets for horses?. The latest findings in laminitis research. The first WALTHAM-Royal Veterinary College Laminitis Conference 2007, 7-14. Equine Veterinary Journal Limited, Suffolk (UK). P.A. Harris, S.J. Hill, J. Elliott (Eds.).
26. Vick M.M., Adams A.A., Murphy B.A., et al. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci 2007, 85(5):1144-1155.
27. Vick M.M., Murphy B.A., Sessions D.R., et al. Effects of systemic inflammation on insulin sensitivity in horses and inflammatory cytokine expression in adipose tissue. Am J Vet Res 2008, 69(1):130-139.
28. Bailey S.R., Habershon-Butcher J.L., Ransom K.J., et al. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res 2008, 69(1):122-129.
29. Rugh K.S., Garner H.E., Sprouse R.F., et al. Left ventricular hypertrophy in chronically hypertensive ponies. Lab Anim Sci 1987, 37:335-338.
30. Buff P.R., Johnson P.J., Wiedmeyer C.E., et al. Modulation of leptin, insulin, and growth hormone in obese pony mares under chronic nutritional restriction and supplementation with ractopamine hydrochloride. Vet Ther 2006, 7(1):64-72.
31. Alford P., Geller S., Richrdson B., et al. A multicenter, matched case-control study of risk factors for equine laminitis. Prev Vet Med 2001, 49(3-4):209-222.
32. Jeffcott L.B., Field J.R., McLean J.G., et al. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 1986, 18(2):97-101.
33. Field J.R., Jeffcott L.B. Equine laminitis-another hypothesis for pathogenesis. Med Hypotheses 1989, 30(3):203-210.
34. Henneke D.R., Potter G.D., Kreider J.L., et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983, 15(4):371-372.
35. Carter R.A., Geor R.J., Burton Staniar W., et al. Apparent adiposity assessed by standardized scoring systems and morphometric measurements in horses and ponies. Vet J 2009, 179(2):204-210.
36. Johnson P.J., Messer N.T., Ganjam V.K., et al. Pregnancy-associated laminitis in mares. J Equine Vet Sci 2009, 29(1):42-46.
37. Johnson PJ, Ganjam VK, Messer NT, et al. The obesity paradigm: an introduction to the emerging discipline of adipobiology. Presented at 52nd Annual Convention of the American Association of Equine Practitioners. San Antonio (TX), December 2-6, 2006.
38. Johnson P.J., Slight S.H., Ganjam V.K., et al. Glucocorticoids and laminitis in the horse. Vet Clin North Am Equine Pract 2002, 18:219-236.
39. Pass M.A., Pollitt S., Pollitt C.C. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J Suppl 1998, 26:133-138.
40. Asplin K.E., McGowan C.M., Pollitt C.C., et al. Role of insulin in glucose uptake in the equine hoof. J Vet Intern Med 2007, 21:668. [abstract].
41. Poitout V., Robertson R.P. Minireview: secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002, 143:339-342.
42. Kim J.K., Montagnani M., Koh K.K., et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
43. Spinler S.A. Challenges associated with metabolic syndrome. Pharmacotherapy 2006, 26(12 Pt 2). 209S-17S.
44. Eades S.C., Stokes A.M., Johnson P.J., et al. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin glucose obtained from horses following carbohydrate overload. Am J Vet Res 2007, 68:87-94.
45. Asplin K.E., Sillence M.N., Pollitt C.C., et al. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 2007, 174(3):530-535.
46. Nourian A.R., Asplin K.E., McGowan C.M., et al. Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia. Equine Vet J 2009, 41(7):671-677.
47. Mora S., Pessin J.E. An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev 2002, 18:345-356.
48. Trayhurn P., Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60:329-339.
49. Hotamisligal G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
50. Matsuzawa Y. The role of fat topology in the risk of disease. Int J Obes (Lond) 2008, 32(Suppl 7):S83-S92.
51. Weisberg S.P., McCann D., Desai M. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
52. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
53. Treiber K., Carter R., Gay L., et al. Inflammatory and redox status of ponies with a history of pasture-associated laminitis. Vet Immunol Immunopathol 2009, 129:216-220.
54. Masuzaki H., Paterson J., Shinyama H., et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
55. Seckl J.R., Walker B.R. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue specific amplifier of glucocorticoid action. Endocrinol 2001, 142:1371-1376.
56. Rask E., Olsson T., Soderberg S., et al. Tissue specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001, 86:1418-1421.
57. Kotelevtsev Y., Holmes M.C., Burchell A., et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 1997, 94:14924-14929.
58. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
59. Reyna S.M., Ghosh S., Tantiwong P., et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 2008, 57(10):2595-2602.
60. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component in the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
61. Harris P., Geor R.J. Primer on dietary carbohydrates and utility of the glycemic index in equine nutrition. Vet Clin North Am Equine Pract 2009, 25(1):23-37.
62. Watts K.A. Forage and pasture management for laminitic horses. Clin Tech Equine Pract 2004, 3:88-95.
63. Treiber K.H., Kronfeld D.S., Hess T.M., et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005, 66(12):2114-2121.
64. Rijnen K.E., van der Kolk J.H. Determination of reference range values indicative of glucose metabolism and insulin resistance by use of glucose clamp techniques in horses and ponies. Am J Vet Res 2003, 64(10):1260-1264.
65. Firshman A.M., Valberg S.J. Factors affecting clinical assessment of insulin sensitivity in horses. Equine Vet J 2007, 39(6):567-575.
66. Eiler H., Frank N., Andrews F.M., et al. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res 2005, 66(9):1598-1604.
67. Wiedmeyer C.E., Johnson P.J., Cohn L.A., et al. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc 2003, 223(7):987-992.
68. Wiedmeyer C.E., Johnson P.J., Cohn L.A., et al. Evaluation of a continuous glucose monitoring system for use in veterinary medicine. Diabetes Technol Ther 2005, 7(6):885-895.
69. Donaldson M.T., Jorgensen A.J., Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 2004, 224(7):1123-1127.
70. Messer N.T., Johnson P.J. Evidence-based literature pertaining to thyroid dysfunction and Cushing's syndrome in the horse. Vet Clin North Am Equine Pract 2007, 23(2):329-364.
71. McGowan C.M., Frost R., Pfeiffer D.U., et al. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J 2004, 36(3):295-298.
72. Frank N., Sommardahl C.S., Eiler H., et al. Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low-density lipoproteins, and glucose dynamics in healthy adult mares. Am J Vet Res 2005, 66:1032-1038.
73. Frank N., Elliott S.B., Boston R.C. Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am J Vet Res 2008, 69:76-81.
74. Frank N., Buchanan B.R., Elliott S.B. Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses. Am J Vet Res 2008, 69:68-75.
75. Vick M.M., Sessions D.R., Murphy B.A., et al. Obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity. Reprod Fertil Dev 2006, 18(6):609-617.
76. Durham A.E., Rendle D.I., Newton J.E. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance. Equine Vet J 2008, 40(5):493-500.
77. Hustace J.L., Firshman A.M., Mata J.E. Pharmacokinetics and bioavailability of metformin in horses. Am J Vet Res 2009, 70(5):665-668.
78. Pajak B., Orzechowska S., Pijet B., et al. Crossroads of cytokine signaling-the chase to stop muscle cachexia. J Physiol Pharmacol 2008, 59(Suppl 9):251-264.
79. Waitt L.H., Cebra C.K. Characterization of hypertriglyceridemia and response to treatment with insulin in horses, ponies, and donkeys: 44 cases (1995-2005). J Am Vet Med Assoc 2009, 234(7):915-919.
80. Powell D.M., Reedy S.E., Sessions D.R., et al. Effect of short-term exercise training on insulin sensitivity in obese and lean mares. Equine Vet J Suppl 2002, 34:81-84.
81. Geor R.J., Harris P. Dietary management of obesity and insulin resistance: countering risk for laminitis. Vet Clin North Am Equine Pract 2009, 25(1):51-65.
82. King C., Mansmann R.A. Preventing laminitis in horses: dietary strategies for horse owners. Clin Tech Equine Pract 2004, 3:96-102.